Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2025-12-25 @ 3:00 AM
NCT ID:
NCT01914133
Eligibility Criteria:
Inclusion Criteria:
* be 65 years of age or older,
* be a non-smoker for at least 5 years
* be referred to the falls clinic at Vancouver General Hospital
* have a Folstein test of cognition \> 25/30 to ensure meal log-book compliance
Exclusion Criteria:
* no oral or swallowing issues that would prevent a Meal Test
* subject requiring dialysis due to end-stage renal failure will be excluded
* subjects with evidence on history, physical or blood work of hepatic disease will be excluded since elevated serum transaminases are a potential adverse effect of acarbose
* cannot currently be taking an alpha-glucosidase inhibitor
* cannot have had allergic reactions to alpha-glucosidase inhibitors in the past
* Due to the fact that acarbose is renally excreted, all subjects must have a Creatine Clearance of greater than 25 ml/min
* Subjects with a past history of inflammatory bowel disease, intestinal obstruction, ileus and peptic ulcer disease will be excluded
* Subjects taking carbohydrate-splitting enzymes (such as amylase) will be excluded
* Subjects with chronic respiratory issues requiring treatment will be excluded
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT01914133
Study Brief:
Protocol Section:
NCT01914133